PLUR
Pluri Inc.
NASDAQ: PLUR · HEALTHCARE · BIOTECHNOLOGY
$3.42
+1.48% today
Updated 2026-04-29
Market cap
$36.85M
P/E ratio
—
P/S ratio
27.52x
EPS (TTM)
$-3.31
Dividend yield
—
52W range
$3 – $6
Volume
0.0M
Pluri Inc. (PLUR) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,286.00%
ROE
-1,022.00%
ROA
-50.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-2.44M | — | — | — |
| 2007 | — | $-8.43M | — | — | — |
| 2008 | — | $-10.50M | — | — | — |
| 2009 | — | $-6.64M | — | — | — |
| 2010 | — | $-7.45M | — | — | — |
| 2011 | $-1.68M | $-10.85M | 100.00% | 660.76% | 644.95% |
| 2012 | $716000.00 | $-14.79M | 97.07% | -2,099.30% | -2,066.20% |
| 2013 | $679000.00 | $-21.16M | 97.05% | -3,272.90% | -3,115.61% |
| 2014 | $379000.00 | $-26.93M | 97.10% | -7,348.28% | -7,106.07% |
| 2015 | $379000.00 | $-24.68M | 96.57% | -6,666.75% | -6,511.08% |
| 2016 | $2.85M | $-23.25M | 96.49% | -819.07% | -816.51% |
| 2017 | — | $-27.81M | — | — | — |
| 2018 | $50000.00 | $-26.13M | 96.00% | -67,462.00% | -52,252.00% |
| 2019 | $54000.00 | $-35.31M | 96.30% | -65,800.00% | -65,383.33% |
| 2020 | $23000.00 | $-29.15M | -6,726.09% | -128,156.52% | -126,747.83% |
| 2021 | $0.00 | $-49.87M | — | — | — |
| 2022 | $234000.00 | $-41.24M | -350.00% | -17,774.79% | -17,624.79% |
| 2023 | $287000.00 | $-28.32M | 96.86% | -9,493.38% | -9,867.94% |
| 2024 | $326000.00 | $-20.89M | 98.77% | -6,796.93% | -6,407.36% |
| 2025 | $1.34M | $-22.58M | 48.95% | -1,659.88% | -1,690.34% |